Entera Bio (ENTX) Prepaid Assets (2017 - 2026)
Entera Bio (ENTX) recorded quarterly Prepaid Assets of $566000.0 in Q1 2026, up 255.97% on a QoQ basis from $159000.0 in Q4 2025, and up 9.06% year-over-year from $519000.0 in Q1 2025.
Entera Bio (ENTX) Prepaid Assets (2017 - 2026) Analysis & Trends
Entera Bio has disclosed Prepaid Assets across 9 years of filings, most recently posting $566000.0 for Q1 2026.
- Quarterly Prepaid Assets rose 9.06% year-over-year to $566000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $566000.0 (up 9.06% YoY) and the FY2025 annual result came in at $159000.0, down 14.52% from the prior year.
- Prepaid Assets advanced to $566000.0 in Q1 2026, from $159000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.3 million in Q1 2022 and troughed at $89000.0 in Q3 2024.
- A 5-year average of $480058.8 and a median of $482000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 79.35% — and 2025, when it jumped 194.38%.
- Tracing ENTX's Prepaid Assets over 5 years: stood at $294000.0 in 2022, then declined by 19.05% to $238000.0 in 2023, then dropped by 21.85% to $186000.0 in 2024, then decreased by 14.52% to $159000.0 in 2025, then soared by 255.97% to $566000.0 in 2026.
- Business Quant data shows ENTX's Prepaid Assets at $566000.0 in Q1 2026, $159000.0 in Q4 2025, and $262000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Entera Bio | 57.79 Mn | 53.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 566,000.00 |
| Dec 31, 2025 | 159,000.00 |
| Sep 30, 2025 | 262,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 519,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 482,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Sep 30, 2023 | 431,000.00 |
| Jun 30, 2023 | 650,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Sep 30, 2022 | 634,000.00 |
| Jun 30, 2022 | 922,000.00 |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 254,000.00 |
| Dec 31, 2020 | 261,000.00 |
| Dec 31, 2018 | 109,000.00 |